DIN 02225905 — ZOLADEX LA 10.8 MG
ZOLADEX LA is a implant of Goserelin marketed by TERSERA THERAPEUTICS LLC. The full Goserelin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02225905
- Brand name
- ZOLADEX LA
- Active ingredient
- Goserelin
- Strength
- 10.8 MG
- Dosage form
- IMPLANT
- Route
- SUBCUTANEOUS
- Manufacturer
- TERSERA THERAPEUTICS LLC
- Health Canada status
- MARKETED
- Drug class
- Gonadotropin-releasing hormone (GnRH/LHRH) agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Goserelin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02049325 | ZOLADEX | 3.6 MG | IMPLANT | TERSERA THERAPEUTICS LLC | MARKETED |